ANTX icon

AN2 Therapeutics

31 hedge funds and large institutions have $99.9M invested in AN2 Therapeutics in 2023 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 16 reducing their positions, and 14 closing their positions.

Holders
31
Holders Change
-7
Holders Change %
-18.42%
% of All Funds
0.49%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
3
Reduced
16
Closed
14
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
RhumbLine Advisers
26
RhumbLine Advisers
Massachusetts
$14.3K 1,677 -10,033 -86%
Fidelity Investments
27
Fidelity Investments
Massachusetts
$5.7K 670 +363 +118%
Royal Bank of Canada
28
Royal Bank of Canada
Ontario, Canada
$2K 186 -456 -71%
Osaic Holdings
29
Osaic Holdings
Arizona
$1.7K 200
New York State Common Retirement Fund
30
New York State Common Retirement Fund
New York
$1K 101 -5,778 -98%
Wells Fargo
31
Wells Fargo
California
$298 35 -1,931 -98%
Northern Trust
32
Northern Trust
Illinois
-76,134 Closed
Bank of New York Mellon
33
Bank of New York Mellon
New York
-31,684 Closed
Charles Schwab
34
Charles Schwab
California
-29,898 Closed
Nuveen Asset Management
35
Nuveen Asset Management
Illinois
-15,546 Closed
JPMorgan Chase & Co
36
JPMorgan Chase & Co
New York
-8,511 Closed
Deutsche Bank
37
Deutsche Bank
Germany
-6,815 Closed
AIG
38
American International Group
New York
-5,362 Closed
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
-4,131 Closed
TRCT
40
Tower Research Capital (TRC)
New York
-2,797 Closed
SO
41
STRS Ohio
Ohio
-2,300 Closed
AB
42
Amalgamated Bank
New York
-1,767 Closed
Legal & General Group
43
Legal & General Group
United Kingdom
-1,166 Closed
AIP
44
Ameritas Investment Partners
Nebraska
-348 Closed
Nisa Investment Advisors
45
Nisa Investment Advisors
Missouri
-10 Closed
CFGS
46
Concourse Financial Group Securities
Alabama